Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.41 |
| ▸ | FNTB | P49356 | 1/20 | 0.41 |
| ▸ | TYMS | P04818 | 1/20 | 0.40 |
| ▸ | GART | P22102 | 1/20 | 0.40 |
| ▸ | ATIC | P31939 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24179874 | 0.90 | GLP1R (0.48) | GLP1RNOD1FOLH1 | |
| SCHEMBL21172208 | 0.90 | GLP1R (0.52) | GLP1RNOD1FOLH1EPHX2FNTA | |
| SCHEMBL21172323 | 0.90 | GLP1R (0.48) | GLP1RNOD1FOLH1FNTAFNTB | |
| SCHEMBL12518529 | 0.90 | GLP1R (0.48) | GLP1RNOD1FOLH1EPHX2FNTA | |
| SCHEMBL19270619 | 0.90 | GLP1R (0.48) | GLP1RNOD1FOLH1EPHX2FNTA | |
| SCHEMBL21170437 | 0.87 | NOD1 (0.53) | GLP1RNOD1FOLH1EPHX2FNTA | |
| SCHEMBL14238759 | 0.83 | NOD1 (0.58) | GLP1RNOD1 | |
| SCHEMBL16478765 | 0.83 | NOD1 (0.51) | GLP1RNOD1FOLH1 | |
| SCHEMBL14238767 | 0.83 | NOD1 (0.54) | GLP1RNOD1 | |
| SCHEMBL17551910 | 0.82 | NOD1 (0.50) | GLP1RNOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |